
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. (TARA)
WebsitePrice
Market cap
Next catalystExpected Q4 2026IV Choline Chloride — THRIVE-3 · Phase 2/3 dataCompany release ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved